Page 16 - Bringing UHN into Focus - 2015-2016 Year in Review

ITApTr/R15AMNaSy/F15OJRunM/15ATJuIlO/15N Aug/15 Sept/15 Oct/15 Nov/15 Dec/15 Jan/16 Feb/16 Mar/16

Research and Innovation:
IRnESEtAeRCgHrANaDlINtNoOVAUTIOHN N’s mission

MICHENER INTEGRATION

The individuals and teams leading the work on Research and Innovation,
including members of the Senior Management Team, report in to Drs.
David Jaffray, EVP Technology & Innovation, and Chris Paige, EVP
Science & Research (Interim). (Photos: UHN)

Each day ideas are sparked that, if given the proper One of many examples of these partnerships is
support, can be stoked into a roaring fire with the the ongoing creation of a state-of-the-art Good
potential to change the way care is delivered. We have Manufacturing Practice (GMP) cell manufacturing
seen this throughout UHN’s 200-year history, from facility— the Centre for Cell and Vector Production
the discovery of blood-forming stem cells, to studying (CCVP)—which will be located on the 9th floor of the
and creating electronic skins. Research and innovation MaRS Phase 2 Tower. Cell-based therapies provide
are integral to UHN’s mission. an enormous opportunity to alter the landscape of
incurable diseases; this facility will enable the scalable
Simply looking at the numbers you can see why production for cell therapy and drug development.
the research taking place here has a global impact. It will be established and co-operated by the Centre
As Canada’s top-funded research hospital, we have for Commercialization of Regenerative Medicine
more than 1,200 researchers, 1,307 trainees and (CCRM) in partnership with UHN. GE Healthcare
2,078 staff generating more than 3,400 papers each and FedDev Ontario recently committed $40M
year. Growth in research is happening in every part towards CCRM’s efforts in building its centre to
of the organization – from individual labs to teams accelerate the development and adoption of cell
working across departments and with other partner manufacturing technologies.
organizations.

16 Bringing UHN into Focus